Basilar Artery Occlusion: Clinical Trials

3 trials for Basilar Artery Occlusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1
Phase 21Recruiting 1

Follow Basilar Artery Occlusion: new trials by email Literature Review of Basilar Artery Occlusion trials Research Report on Basilar Artery Occlusion

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion
Intravenous thrombolysis, Endovascular thrombectomy - Basilar Artery Occlusion, Acute Cerebrovascular Accident
Phase 3CompletedThe First Affiliated Hospital of University of Science and Technology of China3382023-05-092026-08-12
Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion
Tenecteplase, Endovascular thrombectomy - Basilar Artery Occlusion, Acute Cerebrovascular Accident
Phase 3CompletedThe First Affiliated Hospital of University of Science and Technology of China3302023-03-162026-02-18
Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
Tenecteplase, Standard Care (which may include intravenous Alteplase) - Basilar Artery Occlusion
Phase 2 / Phase 3RecruitingUniversity of Melbourne6882021-11-292026-05-06

Narrower conditions

Stroke (3)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Ischemic Stroke (1)  ·  Nervous System Diseases (1)  ·  Vascular Diseases (1)

Broader conditions

Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Nervous System Diseases (2)  ·  Vascular Diseases (2)

Interventions

Tenecteplase (3)  ·  Standard of Care (1)  ·  TNK-tissue plasminogen activator (1)  ·  Thrombectomy (1)  ·  Tissue Plasminogen Activator (1)

Sponsors

The First Affiliated Hospital of University of Science and Technology of China (2)  ·  University of Melbourne (1)

Countries

China (2)  ·  Australia (1)  ·  Brazil (1)  ·  France (1)

Top investigators

Wei Hu, MD (2)  ·  Bruce Campbell (1)  ·  Fana Alemseged (1)

Results publications

PMID 41946560, PMID 42586736, PMID 42776543